Epidermolysis Bullosa: A Case Report

Epidermolysis bullosa (EB) encompasses rare genetic skin fragility disorders caused by mutations in over 20 distinct genes, characterized by mucocutaneous fragility and blistering, with no curative therapy. A 37-year-old male with consanguineous parents presented with a 6-year history of recurrent painful oral erosions refractory to traditional Chinese medicine and lifelong generalized cutaneous exfoliation. Oral examination revealed extensive erythematous erosions with leukoplakic changes, positive Nikolsky sign, enamel pitting, microstomia, and severe periodontitis. Cutaneous manifestations include generalized exfoliation with hyperpigmentation, hypotrichosis, and hyperhidrosis. Musculoskeletal abnormalities included limb deformities, digital contractures, and nail dystrophy. Buccal mucosal biopsy revealed mucosal hyperkeratosis with parakeratosis, basal layer liquefaction, and dense chronic inflammatory infiltrates. The constellation of consanguineous parentage, multisystem involvement, and histopathological findings supports a provisional diagnosis of epidermolysis bullosa (EB), immunofluorescence mapping and genetic sequencing are recommended for confirmation. The patient has been enrolled in a multidisciplinary team (oral medicine/dermatology/pain/psychology). Our department initiated local symptomatic treatment with improvement in oral lesions. EB diagnosis relies on the combined use of immunofluorescence mapping, transmission electron microscopy, and genetic sequencing. Current management focuses on pain control, wound care, minimization of complications, and carcinogenesis surveillance. Novel antibody and cytokine therapies show promising potential. Key shortcomings requiring improvement include diagnostic delays, limited treatment, inadequate SCC surveillance, and neglected mental health support. EB diagnosis requires multimodal evaluation with selective genetic testing to prevent misdiagnosis. Multidisciplinary therapy effectively controls symptoms and reduces complications.

Authors

Institutions

Publication Details

Journal
International Dental Journal
Published
2025-10-01
DOI
https://doi.org/10.1016/j.identj.2025.106043
Primary Topic
Skin and Cellular Biology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epidermolysis Bullosa: A Case Report

Xinyu Zhang, Xiang‐Nan Jiang
International Dental Journal
Skin and Cellular Biology Research
article

Epidermolysis Bullosa: A Case Report

Xinyu Zhang, Xiang‐Nan Jiang
article en

Abstract

Epidermolysis bullosa (EB) encompasses rare genetic skin fragility disorders caused by mutations in over 20 distinct genes, characterized by mucocutaneous fragility and blistering, with no curative therapy. A 37-year-old male with consanguineous parents presented with a 6-year history of recurrent painful oral erosions refractory to traditional Chinese medicine and lifelong generalized cutaneous exfoliation. Oral examination revealed extensive erythematous erosions with leukoplakic changes, positive Nikolsky sign, enamel pitting, microstomia, and severe periodontitis. Cutaneous manifestations include generalized exfoliation with hyperpigmentation, hypotrichosis, and hyperhidrosis. Musculoskeletal abnormalities included limb deformities, digital contractures, and nail dystrophy. Buccal mucosal biopsy revealed mucosal hyperkeratosis with parakeratosis, basal layer liquefaction, and dense chronic inflammatory infiltrates. The constellation of consanguineous parentage, multisystem involvement, and histopathological findings supports a provisional diagnosis of epidermolysis bullosa (EB), immunofluorescence mapping and genetic sequencing are recommended for confirmation. The patient has been enrolled in a multidisciplinary team (oral medicine/dermatology/pain/psychology). Our department initiated local symptomatic treatment with improvement in oral lesions. EB diagnosis relies on the combined use of immunofluorescence mapping, transmission electron microscopy, and genetic sequencing. Current management focuses on pain control, wound care, minimization of complications, and carcinogenesis surveillance. Novel antibody and cytokine therapies show promising potential. Key shortcomings requiring improvement include diagnostic delays, limited treatment, inadequate SCC surveillance, and neglected mental health support. EB diagnosis requires multimodal evaluation with selective genetic testing to prevent misdiagnosis. Multidisciplinary therapy effectively controls symptoms and reduces complications.

International Dental JournalVol. 75
Guilin Medical University (CN)
Openalex Percentile: Top 66%
Skin and Cellular Biology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Epidermolysis Bullosa: A Case Report — Xinyu Zhang, Xiang‐Nan Jiang · International Dental Journal (2025) | TGRS Research Map | TGRS